Nitrosamine Impurities Testing

Nitrosamine Impurities Testing

Products
Nitrosamine Impurities Testing
Nitrosamine Impurities Testing

Information

SGS Life Sciences has considerable expertise in the method development of nitrosamine determination in pharmaceutical products. SGS has established a specific method for NDMA which can be applied to various different matrices. Alternatively, a platform method, based on trace-level detection by LC-MSMS, is also available and provides rapid and simultaneous determination of up to ten different, targeted nitrosamines. Although with more limited application, the SGS network is also able to support specialist methodologies such as GC-MSMS. Our experience in optimizing extraction procedures allows application of these methods to drug products, API's, and raw materials.
Main Categories
APIs (Active Pharmaceutical Ingredients)Biopharmaceuticals
All Categories
Analytical ChemistryAPIs (Active Pharmaceutical Ingredients)Biopharmaceuticals
Distribution areas
North America (USA, Canada)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)
Supplied from
United States

Log in

See all the content and easy-to-use features by logging in or registering!